https://news.medxy.ai/zh/gildeuretinol-stargardt-safety/Medxy AIzh2026-09-07T10:53:24-07:00gildeuretinol acetate 对 Stargardt 病视网膜萎缩性病灶的安全性与疗效：来自 TEASE-1 随机临床试验的启示 https://news.medxy.ai/ja/gildeuretinol-safety-stargardt/Medxy AIja2026-09-07T10:52:57-07:00Stargardt病における網膜萎縮病変へのGildeuretinol acetateの安全性と効果：TEASE-1無作為化臨床試験からの知見 https://news.medxy.ai/vi/71420-2/Medxy AIvi2026-09-07T10:52:28-07:00Tính an toàn và hiệu quả của Gildeuretinol Acetate đối với các tổn thương teo võng mạc trong bệnh Stargardt: Những thông tin từ thử nghiệm lâm sàng ngẫu nhiên TEASE-1 https://news.medxy.ai/safety-and-effects-of-gildeuretinol-acetate-on-retinal-atrophic-lesions-in-stargardt-disease-insights-from-the-tease-1-randomized-clinical-trial/Medxy AIen2026-09-07T10:52:02-07:00Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: Insights from the TEASE-1 Randomized Clinical Trial https://news.medxy.ai/zh/thyroid-cancer-recurrence/Medxy AIzh2026-09-07T10:51:06-07:00髓样甲状腺癌分区复发新观察：对侧预防性中央区颈清扫是否必要？ https://news.medxy.ai/ja/71411-2/Medxy AIja2026-09-07T10:50:40-07:00甲状腺髄様癌の局所再発に関する新たな知見：対側中心区域頸部リンパ節の予防的郭清は必要か？ https://news.medxy.ai/vi/thyroid-cancer-lymph-node-recurrence/Medxy AIvi2026-09-07T10:50:15-07:00Tái phát hạch theo khoang trong ung thư tuyến giáp thể tủy: Đánh giá vai trò của nạo vét hạch trung tâm dự phòng đối bên https://news.medxy.ai/compartment-specific-nodal-recurrence-in-medullary-thyroid-cancer-evaluating-the-role-of-contralateral-prophylactic-central-neck-dissection/Medxy AIen2026-09-07T10:49:52-07:00Compartment-Specific Nodal Recurrence in Medullary Thyroid Cancer: Evaluating the Role of Contralateral Prophylactic Central Neck Dissection https://news.medxy.ai/protocol-based-early-intensive-lipid-management-significantly-enhances-ldl-c-target-achievement-post-acute-coronary-syndrome-insights-from-the-bridge-trial/Medxy AIen2026-09-07T10:49:31-07:00Protocol-Based Early Intensive Lipid Management Significantly Enhances LDL-C Target Achievement Post-Acute Coronary Syndrome: Insights from the BRIDGE Trial https://news.medxy.ai/zh/optimized-ctdna-monitoring/Medxy AIzh2026-09-07T10:49:12-07:00优化头颈鳞状细胞癌监测：组织指导型ctDNA检测显示出高准确性与良好可行性 https://news.medxy.ai/ja/head-and-neck-cancer-monitoring/Medxy AIja2026-09-07T10:48:50-07:00頭頸部扁平上皮癌のモニタリング最適化：tissue-informed ctDNAアッセイが高精度と実用性を示す https://news.medxy.ai/vi/ctdna-cancer-monitoring/Medxy AIvi2026-09-07T10:48:24-07:00Tối ưu hóa theo dõi ung thư biểu mô tế bào vảy vùng đầu và cổ: Xét nghiệm ctDNA có nguồn gốc từ mô cho thấy độ chính xác cao và tính khả thi tốt https://news.medxy.ai/optimizing-monitoring-in-head-and-neck-squamous-cell-carcinoma-tissue-informed-ctdna-assay-shows-high-accuracy-and-feasibility/Medxy AIen2026-09-07T10:47:56-07:00Optimizing Monitoring in Head and Neck Squamous Cell Carcinoma: Tissue-Informed ctDNA Assay Shows High Accuracy and Feasibility https://news.medxy.ai/zh/hormone-therapy-voice/Medxy AIzh2026-09-07T10:47:13-07:00激素替代治疗会影响嗓音吗？大型 TriNetX 队列揭示围绝经期与绝经后女性的声音障碍风险 https://news.medxy.ai/ja/71396-2/Medxy AIja2026-09-07T10:46:53-07:00ホルモン補充療法は声に影響を及ぼしますか？ https://news.medxy.ai/vi/voice-disorder-risk/Medxy AIvi2026-09-07T10:46:26-07:00Đánh giá nguy cơ rối loạn giọng nói ở phụ nữ tiền mãn kinh và hậu mãn kinh dùng liệu pháp thay thế hormone: Phát hiện từ một đoàn hệ lớn TriNetX https://news.medxy.ai/evaluating-voice-disorder-risks-in-peri-and-post-menopausal-women-using-hormone-replacement-therapy-insights-from-a-large-trinetx-cohort/Medxy AIen2026-09-07T10:46:01-07:00Evaluating Voice Disorder Risks in Peri- and Post-Menopausal Women Using Hormone Replacement Therapy: Insights from a Large TriNetX Cohort https://news.medxy.ai/zh/differentiated-thyroid-cancer/Medxy AIzh2026-09-07T10:45:22-07:00分化型甲状腺癌气管侵犯的优化处理：来自两阶段气管修复研究的启示 https://news.medxy.ai/ja/tracheal-infiltration-thyroid-cancer/Medxy AIja2026-09-07T10:45:00-07:00高分化型甲状腺癌における気管浸潤への対応：2期的気管修復研究からみた知見 https://news.medxy.ai/vi/tracheal-invasion-management/Medxy AIvi2026-09-07T10:44:37-07:00Tối ưu hóa xử trí xâm lấn khí quản trong ung thư biểu mô tuyến giáp biệt hóa tốt: Góc nhìn từ nghiên cứu sửa chữa khí quản hai thì https://news.medxy.ai/optimizing-management-of-tracheal-invasion-in-well-differentiated-thyroid-carcinoma-insights-from-a-two-stage-tracheal-repair-study/Medxy AIen2026-09-07T10:44:14-07:00Optimizing Management of Tracheal Invasion in Well-Differentiated Thyroid Carcinoma: Insights from a Two-Stage Tracheal Repair Study https://news.medxy.ai/zh/us-liver-transplant-safety/Medxy AIzh2026-09-07T10:43:36-07:00美国新建活体供肝移植项目的安全实践：学习曲线揭示的经验与启示 https://news.medxy.ai/ja/safe-living-liver-donation/Medxy AIja2026-09-07T10:43:14-07:00新規米国LDLTプログラムが示す安全な生体肝提供の前進：学習曲線から見えた知見 https://news.medxy.ai/vi/living-donor-liver-safety/Medxy AIvi2026-09-07T10:42:39-07:00Nâng cao tính an toàn của hiến gan sống: Bài học từ đường cong học tập của một chương trình ghép tạng mới tại Hoa Kỳ https://news.medxy.ai/safe-living-liver-donation-2/Medxy AIen2026-09-07T10:42:16-07:00Advancing Safe Living Liver Donation: Insights from a New U.S. Transplant Program’s Learning Curve https://news.medxy.ai/zh/lung-metastasis-after-gastrectomy/Medxy AIzh2026-09-07T10:41:32-07:00胃癌胃切除术后肺转移：临床结局与预后因素分析 https://news.medxy.ai/ja/lung-metastasis-stomach-cancer/Medxy AIja2026-09-07T10:41:12-07:00胃癌胃切除後肺転移の臨床転帰と予後因子 https://news.medxy.ai/vi/lung-metastasis-gastrectomy/Medxy AIvi2026-09-07T10:40:51-07:00Di căn phổi sau cắt dạ dày vì ung thư dạ dày: Kết cục lâm sàng và các yếu tố tiên lượng https://news.medxy.ai/clinical-outcomes-and-prognostic-factors-in-lung-metastases-following-gastrectomy-for-gastric-cancer/Medxy AIen2026-09-07T10:40:31-07:00Clinical Outcomes and Prognostic Factors in Lung Metastases Following Gastrectomy for Gastric Cancer https://news.medxy.ai/zh/us-surgeon-workload/Medxy AIzh2026-09-07T10:39:49-07:00美国外科医生工作负荷高且负担感明显：全国调查揭示关键影响因素 https://news.medxy.ai/ja/surgeon-workload/Medxy AIja2026-09-07T10:39:21-07:00外科医の過重な業務負担と主観的負担：米国全国調査から見えた実態 https://news.medxy.ai/vi/71359-2/Medxy AIvi2026-09-07T10:38:54-07:00Khối lượng công việc quá tải và gánh nặng chủ quan đối với các phẫu thuật viên: Thực trạng được hé lộ qua một cuộc khảo sát toàn quốc tại Hoa Kỳ https://news.medxy.ai/high-surgical-workload-and-perceived-burden-insights-from-a-national-survey-of-us-surgeons/Medxy AIen2026-09-07T10:38:29-07:00High Surgical Workload and Perceived Burden: Insights from a National Survey of US Surgeons https://news.medxy.ai/zh/exosome-microrna-pancreatic-cancer/Medxy AIzh2026-09-07T10:37:43-07:00循环外泌体 microRNA 特征助力胰腺癌术前识别隐匿性肝转移 https://news.medxy.ai/ja/pancreatic-cancer-liver-metastasis/Medxy AIja2026-09-07T10:37:21-07:00循環エクソソーム miRNA シグネチャーで膵がんの潜在性肝転移を術前に高精度検出 https://news.medxy.ai/vi/exosomal-mirna-detection/Medxy AIvi2026-09-07T10:36:58-07:00Chữ ký exosomal microRNA lưu hành giúp phát hiện sớm di căn gan tiềm ẩn trước phẫu thuật ở ung thư tụy https://news.medxy.ai/circulating-exosomal-microrna-signature-enhances-preoperative-detection-of-occult-liver-metastases-in-pancreatic-cancer/Medxy AIen2026-09-07T10:36:34-07:00Circulating Exosomal microRNA Signature Enhances Preoperative Detection of Occult Liver Metastases in Pancreatic Cancer https://news.medxy.ai/zh/esophageal-hernia-repair/Medxy AIzh2026-09-07T10:35:52-07:00复杂食管旁疝修补中后腹直肌鞘皮瓣用于持久性食管裂孔增补的疗效评估 https://news.medxy.ai/ja/posterior-rectus-sheath-flap-use/Medxy AIja2026-09-07T10:35:25-07:00複雑な傍食道ヘルニア修復における後腹直筋鞘皮弁の有用性を検証する https://news.medxy.ai/vi/abdominal-muscle-flap/Medxy AIvi2026-09-07T10:34:59-07:00Đánh giá vạt cân cơ thẳng bụng sau trong tăng cường khe hoành bền vững cho sửa chữa thoát vị cạnh thực quản phức tạp https://news.medxy.ai/evaluating-the-posterior-rectus-sheath-flap-for-durable-hiatal-augmentation-in-complex-paraesophageal-hernia-repair/Medxy AIen2026-09-07T10:34:34-07:00Evaluating the Posterior Rectus Sheath Flap for Durable Hiatal Augmentation in Complex Paraesophageal Hernia Repair https://news.medxy.ai/ja/chronic-pancreatitis-surgery-2/Medxy AIja2026-09-07T10:33:52-07:00慢性膵炎の形態別手術を再考する：欧州多施設研究が示した課題と、統一ガイドライン刷新の必要性 https://news.medxy.ai/vi/morphology-based-surgery/Medxy AIvi2026-09-07T10:33:03-07:00Phẫu thuật dựa trên hình thái trong viêm tụy mạn: phát hiện từ nghiên cứu toàn châu Âu và nhu cầu xây dựng hướng dẫn thống nhất thế hệ mới https://news.medxy.ai/zh/chronic-pancreatitis-surgery/Medxy AIzh2026-09-07T10:32:13-07:00慢性胰腺炎的形态学导向手术：欧洲多中心研究发现与统一新一代指南的必要性 https://news.medxy.ai/morphology-based-surgery-for-chronic-pancreatitis-findings-from-a-europe-wide-study-and-the-case-for-unified-next-generation-guidelines/Medxy AIen2026-09-07T10:31:28-07:00Morphology-Based Surgery for Chronic Pancreatitis: Findings from a Europe-Wide Study and the Case for Unified, Next-Generation Guidelines https://news.medxy.ai/zh/innovative-nerve-sparing-laparoscopy/Medxy AIzh2026-09-07T10:30:20-07:00直肠子宫内膜异位症的创新保留神经腹腔镜术式：保留肠系膜的手工缝合吻合 https://news.medxy.ai/ja/nerve-sparing-laparoscopy/Medxy AIja2026-09-07T10:29:54-07:00直腸子宮内膜症に対する新しい神経温存腹腔鏡手技：腸間膜温存手縫い吻合 https://news.medxy.ai/vi/nerve-sparing-endometriosis-surgery/Medxy AIvi2026-09-07T10:29:24-07:00Kỹ thuật nội soi bảo tồn thần kinh, bảo tồn mạc treo trong điều trị lạc nội mạc tử cung trực tràng: nối khâu tay không dùng stapler https://news.medxy.ai/innovative-nerve-sparing-laparoscopic-approach-for-rectal-endometriosis-mesentery-preserving-hand-sewn-anastomosis/Medxy AIen2026-09-07T10:28:58-07:00Innovative Nerve-Sparing Laparoscopic Approach for Rectal Endometriosis: Mesentery-Preserving Hand-Sewn Anastomosis https://news.medxy.ai/zh/71317-2/Medxy AIzh2026-09-07T10:28:12-07:00胎儿镜激光消融术后出现双胎输血综合征后六个月生存情况 https://news.medxy.ai/ja/71315-2/Medxy AIja2026-09-07T10:27:46-07:00双胎間輸血症候群に対する胎児鏡下レーザー凝固術後の6ヶ月生存予測：術前の主要指標と経時的転帰 https://news.medxy.ai/vi/fetal-laser-survival/Medxy AIvi2026-09-07T10:27:15-07:00Dự báo sống còn sau 6 tháng sau đốt laser qua nội soi thai nhi trong hội chứng truyền máu song thai: các yếu tố trước thủ thuật và xu hướng theo thời gian https://news.medxy.ai/predicting-six-month-survival-after-fetoscopic-laser-ablation-in-twin-twin-transfusion-syndrome-key-pre-procedure-indicators-and-temporal-outcomes/Medxy AIen2026-09-07T10:26:45-07:00Predicting Six-Month Survival After Fetoscopic Laser Ablation in Twin-Twin Transfusion Syndrome: Key Pre-Procedure Indicators and Temporal Outcomes https://news.medxy.ai/zh/71308-2/Medxy AIzh2026-09-07T10:26:00-07:00产后肛提肌重塑——产妇年龄与对盆底健康的影响 https://news.medxy.ai/ja/postpartum-levator-ani-remodeling/Medxy AIja2026-09-07T10:25:29-07:00産後の肛門挙筋リモデリングを読み解く：母体年齢と回復期間が骨盤底の健康に及ぼす影響 https://news.medxy.ai/vi/71305-2/Medxy AIvi2026-09-07T10:25:00-07:00Giải mã quá trình tái cấu trúc cơ nâng hậu môn sau sinh: Tác động của độ tuổi người mẹ và giai đoạn hồi phục đối với sức khỏe sàn chậu https://news.medxy.ai/insights-into-postpartum-levator-ani-muscle-remodeling-impact-of-maternal-age-and-recovery-duration-on-pelvic-floor-health/Medxy AIen2026-09-07T10:24:31-07:00Insights into Postpartum Levator Ani Muscle Remodeling: Impact of Maternal Age and Recovery Duration on Pelvic Floor Health https://news.medxy.ai/zh/uterine-fibroid-molecular-types/Medxy AIzh2026-09-07T10:23:38-07:00子宫平滑肌瘤的分子分型：大型回顾性队列中的临床意义与基于MRI的预测分诊 https://news.medxy.ai/ja/uterine-fibroid-subtypes/Medxy AIja2026-09-07T10:23:07-07:00子宮平滑筋腫の分子サブタイプを読み解く：臨床的意義とMRIによる予測トリアージを大規模後ろ向きコホートで検討 https://news.medxy.ai/vi/uterine-fibroid-subgroups/Medxy AIvi2026-09-07T10:22:35-07:00Các phân nhóm phân tử của u xơ tử cung tử cung: ý nghĩa lâm sàng và phân tầng tiên lượng bằng MRI trong một đoàn hệ hồi cứu quy mô lớn https://news.medxy.ai/molecular-subtypes-of-uterine-leiomyomas-clinical-implications-and-mri-based-predictive-triage-in-a-large-retrospective-cohort/Medxy AIen2026-09-07T10:22:09-07:00Molecular Subtypes of Uterine Leiomyomas: Clinical Implications and MRI-Based Predictive Triage in a Large Retrospective Cohort https://news.medxy.ai/zh/high-dose-oxytocin/Medxy AIzh2026-09-07T10:21:19-07:00高剂量缩宫素用于第三产程：降低产后出血的实践证据 https://news.medxy.ai/ja/postpartum-bleeding-control/Medxy AIja2026-09-07T10:21:00-07:00分娩第3期の高用量オキシトシンで産後出血を抑制：品質改善研究から見えた実践的知見 https://news.medxy.ai/vi/high-dose-oxytocin-2/Medxy AIvi2026-09-07T10:20:39-07:00Phác đồ oxytocin liều cao trong giai đoạn ba của chuyển dạ giúp giảm băng huyết sau sinh https://news.medxy.ai/high-dose-oxytocin-protocol-in-third-stage-labor-reduces-postpartum-hemorrhage-insights-from-a-quality-improvement-study/Medxy AIen2026-09-07T10:20:17-07:00High-Dose Oxytocin Protocol in Third-Stage Labor Reduces Postpartum Hemorrhage: Insights from a Quality-Improvement Study https://news.medxy.ai/zh/71280-2/Medxy AIzh2026-09-07T10:19:37-07:00复方口服避孕药的演变与安全性 https://news.medxy.ai/ja/evolution-oral-contraceptives/Medxy AIja2026-09-07T10:19:14-07:00複合経口避妊薬の進化と安全性：臨床的意義を読み解く https://news.medxy.ai/vi/oral-contraceptives-safety/Medxy AIvi2026-09-07T10:18:43-07:00Thuốc tránh thai phối hợp đường uống: tiến triển, độ an toàn và ý nghĩa lâm sàng https://news.medxy.ai/combined-oral-contraception-evolution-safety-and-clinical-implications/Medxy AIen2026-09-07T10:18:15-07:00Combined Oral Contraception: Evolution, Safety, and Clinical Implications https://news.medxy.ai/ja/drug-induced-liver-injury/Medxy AIja2026-09-07T10:17:01-07:00臨床試験における薬物性肝障害を読み解く：FDA専門家が示す最新知見と論点 https://news.medxy.ai/vi/drug-induced-liver-injury-2/Medxy AIvi2026-09-07T10:16:34-07:00Vượt qua thách thức tổn thương gan do thuốc trong thử nghiệm lâm sàng: Góc nhìn và cập nhật từ chuyên gia FDA https://news.medxy.ai/navigating-drug-induced-liver-injury-in-clinical-trials-insights-and-updates-from-fda-experts/Medxy AIen2026-09-07T10:16:05-07:00Navigating Drug-Induced Liver Injury in Clinical Trials: Insights and Updates from FDA Experts https://news.medxy.ai/zh/71262-2/Medxy AIzh2026-09-06T10:15:16-07:00VCTE 测定的肝脏硬度降低 30%可能作为MASH 组织学改善的关键指标？ https://news.medxy.ai/ja/liver-stiffness-decrease/Medxy AIja2026-09-06T10:14:46-07:00MASHにおける組織学的改善を見抜く鍵：VCTE由来肝硬度が30％低下したときの臨床的意義 https://news.medxy.ai/vi/71257-2/Medxy AIvi2026-09-06T10:14:11-07:00Chìa khóa xác định sự cải thiện về mô học trong MASH: Ý nghĩa lâm sàng của việc giảm 30% độ cứng gan đo bằng VCTE https://news.medxy.ai/clinical-utility-of-a-30-reduction-in-vcte-derived-liver-stiffness-measurement-for-identifying-histologic-improvement-in-metabolic-dysfunction/Medxy AIen2026-09-06T10:13:33-07:00Clinical Utility of a 30% Reduction in VCTE-Derived Liver Stiffness Measurement for Identifying Histologic Improvement in Metabolic Dysfunction-Associated Steatohepatitis https://news.medxy.ai/zh/71748-2/Medxy AIzh2026-09-06T10:12:55-07:00妊娠期抗癫痫药物浓度的变化及多药联合治疗的影响 https://news.medxy.ai/zh/colorectal-cancer-surveillance/Medxy AIzh2026-09-06T10:12:41-07:00重新审视炎症性肠病中的结直肠癌监测：家族史的作用不应仅限于早发病例 https://news.medxy.ai/ja/71746-2/Medxy AIja2026-09-06T10:12:34-07:00抗てんかん薬血中濃度の妊娠に伴う変動と多剤併用療法の影響 https://news.medxy.ai/ja/colorectal-cancer-surveillance-3/Medxy AIja2026-09-06T10:12:18-07:00炎症性腸疾患における大腸がんサーベイランスの再考：早発性例だけではない家族歴の重要性 https://news.medxy.ai/vi/71744-2/Medxy AIvi2026-09-06T10:12:13-07:00Những thay đổi về nồng độ thuốc chống co giật trong thai kỳ và tác động của liệu pháp đa thuốc https://news.medxy.ai/vi/colorectal-cancer-surveillance-2/Medxy AIvi2026-09-06T10:11:51-07:00Rà soát lại chiến lược giám sát ung thư đại trực tràng ở bệnh viêm ruột: Vai trò của tiền sử gia đình vượt ra ngoài các trường hợp khởi phát sớm https://news.medxy.ai/reevaluating-colorectal-cancer-surveillance-in-inflammatory-bowel-disease-the-role-of-family-history-beyond-early-onset-cases/Medxy AIen2026-09-06T10:11:28-07:00Reevaluating Colorectal Cancer Surveillance in Inflammatory Bowel Disease: The Role of Family History Beyond Early-Onset Cases https://news.medxy.ai/zh/tapis-trial-insights/Medxy AIzh2026-09-06T10:10:47-07:00中度缺血性卒中溶栓后替格瑞洛-阿司匹林双联治疗：TAPIS 试验中梗死模式带来的启示 https://news.medxy.ai/ja/dual-antiplatelet-therapy-2/Medxy AIja2026-09-06T10:10:21-07:00中等度虚血性脳卒中の血栓溶解後におけるチカグレロル・アスピリン二重療法：TAPIS試験にみる梗塞パターンの示唆 https://news.medxy.ai/vi/ticagrelor-aspirin-ischemic-stroke/Medxy AIvi2026-09-06T10:09:49-07:00Ticagrelor-aspirin sau tiêu sợi huyết trong đột quỵ thiếu máu cục bộ mức độ vừa: Gợi ý từ kiểu hình nhồi máu trong thử nghiệm TAPIS https://news.medxy.ai/ticagrelor-aspirin-dual-therapy-after-thrombolysis-in-moderate-ischemic-stroke-insights-from-infarct-patterns-in-the-tapis-trial/Medxy AIen2026-09-06T10:09:23-07:00Ticagrelor-Aspirin Dual Therapy After Thrombolysis in Moderate Ischemic Stroke: Insights from Infarct Patterns in the TAPIS Trial https://news.medxy.ai/zh/cilostazol-neuroprotection/Medxy AIzh2026-09-06T10:08:38-07:00西洛他唑治疗脑内出血：通过增强硬脑膜淋巴功能实现神经保护 https://news.medxy.ai/ja/cilostazol-neuroprotection-2/Medxy AIja2026-09-06T10:08:11-07:00脳内出血に対するシロスタゾール治療：硬膜リンパ管機能を高めて神経保護をめざす https://news.medxy.ai/vi/cilostazol-brain-hemorrhage/Medxy AIvi2026-09-06T10:07:45-07:00Cilostazol trong điều trị xuất huyết não: tăng cường chức năng bạch mạch màng cứng để bảo vệ thần kinh https://news.medxy.ai/cilostazol-therapy-in-intracerebral-hemorrhage-enhancing-dural-lymphatic-function-for-neuroprotection/Medxy AIen2026-09-06T10:07:15-07:00Cilostazol Therapy in Intracerebral Hemorrhage: Enhancing Dural Lymphatic Function for Neuroprotection https://news.medxy.ai/zh/csf-markers-severity/Medxy AIzh2026-09-06T10:06:18-07:00脑脊液生物标志物能否提示疑似脑淀粉样血管病的严重程度？MRI之外的新线索 https://news.medxy.ai/ja/brain-amyloid-angiopathy/Medxy AIja2026-09-06T10:05:47-07:00CSFバイオマーカーでみる脳アミロイドアンギオパチーの重症度：MRIを超えて見える病態 https://news.medxy.ai/vi/71223-2/Medxy AIvi2026-09-06T10:05:16-07:00Liệu các dấu ấn sinh học trong dịch não tủy có thể phản ánh mức độ nghiêm trọng của nghi vấn bệnh lý mạch máu não dạng amyloid? Những manh mối mới bên cạnh hình ảnh cộng hưởng từ (MRI) https://news.medxy.ai/csf-biomarkers-as-indicators-of-disease-severity-in-probable-cerebral-amyloid-angiopathy-insights-beyond-mri/Medxy AIen2026-09-06T10:04:46-07:00CSF Biomarkers as Indicators of Disease Severity in Probable Cerebral Amyloid Angiopathy: Insights Beyond MRI https://news.medxy.ai/zh/temporal-lobe-epilepsy-mechanisms/Medxy AIzh2026-09-06T10:03:54-07:00颞叶癫痫中枢自主神经网络紊乱与心肺功能异常有关？ https://news.medxy.ai/ja/central-autonomic-network/Medxy AIja2026-09-06T10:03:30-07:00側頭葉てんかんにおける心肺機能障害の背景にある中枢自律神経ネットワーク異常を解明する https://news.medxy.ai/vi/central-autonomic-dysfunction/Medxy AIvi2026-09-06T10:03:07-07:00Giải mã rối loạn mạng tự chủ trung ương nền tảng cho suy giảm tim hô hấp ở động kinh thùy thái dương https://news.medxy.ai/unraveling-central-autonomic-network-disruptions-underlying-cardiorespiratory-dysfunction-in-temporal-lobe-epilepsy/Medxy AIen2026-09-06T10:02:40-07:00Unraveling Central Autonomic Network Disruptions Underlying Cardiorespiratory Dysfunction in Temporal Lobe Epilepsy https://news.medxy.ai/zh/71207-2/Medxy AIzh2026-09-06T10:01:51-07:001型糖尿病患者的儿科亲属（以同胞为主）中的自身抗体筛查：患病率、决定因素及心理影响 https://news.medxy.ai/ja/type-1-diabetes-siblings/Medxy AIja2026-09-06T10:01:26-07:001型糖尿病患者のきょうだいに着目した小児第一度近親者における自己抗体スクリーニング：有病率・規定因子・心理的影響 https://news.medxy.ai/vi/type-1-diabetes-antibody-screening/Medxy AIvi2026-09-06T10:00:52-07:00Sàng lọc tự kháng thể ở thân nhân trẻ em của bệnh nhân đái tháo đường týp 1, chủ yếu là anh chị em ruột: Tỷ lệ hiện mắc, yếu tố liên quan và tác động tâm lý https://news.medxy.ai/autoantibody-screening-in-sibling-dominant-pediatric-relatives-of-type-1-diabetes-patients-prevalence-determinants-and-psychological-impact/Medxy AIen2026-09-06T10:00:28-07:00Autoantibody Screening in Sibling-Dominant Pediatric Relatives of Type 1 Diabetes Patients: Prevalence, Determinants, and Psychological Impact https://news.medxy.ai/zh/infertility-diabetes-risk-2/Medxy AIzh2026-09-06T09:59:29-07:00不孕史会增加2型糖尿病风险吗？——护士健康研究II揭示的关键线索 https://news.medxy.ai/ja/infertility-diabetes-risk/Medxy AIja2026-09-06T09:59:05-07:00不妊歴と2型糖尿病リスクの関連を探る： Nurses’ Health Study II からの知見 https://news.medxy.ai/vi/female-infertility-diabetes-risk/Medxy AIvi2026-09-06T09:58:39-07:00Tiền sử vô sinh nữ liên quan thế nào đến nguy cơ đái tháo đường type 2? Dữ liệu từ Nurses’ Health Study II https://news.medxy.ai/female-infertility-diabetes-risk-2/Medxy AIen2026-09-06T09:58:11-07:00Linking Female Infertility History to Type 2 Diabetes Risk: Insights from the Nurses’ Health Study II https://news.medxy.ai/zh/71186-2/Medxy AIzh2026-09-06T09:57:27-07:00血液系统恶性肿瘤患儿睾丸功能的纵向评估：见解与临床意义 https://news.medxy.ai/ja/testicular-function-boys-cancer/Medxy AIja2026-09-06T09:56:57-07:00血液悪性腫瘍を有する男児の精巣機能を経時的に評価する：知見と臨床的意義 https://news.medxy.ai/vi/71184-2/Medxy AIvi2026-09-06T09:56:22-07:00Đánh giá dọc chức năng tinh hoàn ở trẻ nam mắc các bệnh ác tính về huyết học: Những hiểu biết và ý nghĩa lâm sàng https://news.medxy.ai/longitudinal-assessment-of-testicular-function-in-boys-with-hematological-malignancies-insights-and-clinical-implications/Medxy AIen2026-09-06T09:55:50-07:00Longitudinal Assessment of Testicular Function in Boys with Hematological Malignancies: Insights and Clinical Implications https://news.medxy.ai/zh/sarcopenic-obesity-diabetes-risk/Medxy AIzh2026-09-06T09:54:53-07:00肌少性肥胖与2型糖尿病风险：来自 UK Biobank 研究的启示 https://news.medxy.ai/ja/sarcopenic-obesity-diabetes-risk-2/Medxy AIja2026-09-06T09:54:28-07:00サルコペニック肥満は2型糖尿病リスクをどこまで高めるのか？ UK Biobank研究が示した新知見 https://news.medxy.ai/vi/obesity-muscle-loss-diabetes-risk/Medxy AIvi2026-09-06T09:54:00-07:00Béo phì kèm giảm cơ và nguy cơ đái tháo đường type 2: Gợi ý từ nghiên cứu UK Biobank https://news.medxy.ai/sarcopenic-obesity-and-type-2-diabetes-risk-insights-from-the-uk-biobank-study/Medxy AIen2026-09-06T09:53:37-07:00Sarcopenic Obesity and Type 2 Diabetes Risk: Insights from the UK Biobank Study https://news.medxy.ai/zh/71171-2/Medxy AIzh2026-09-06T09:52:58-07:001型糖尿病患者月经周期对胰岛素敏感性的影响：来自自动胰岛素输注系统使用者的见解 https://news.medxy.ai/ja/71169-2/Medxy AIja2026-09-06T09:52:35-07:001型糖尿病におけるインスリン感受性への月経周期の影響：自動インスリン投与システム使用者からの知見 https://news.medxy.ai/vi/menstrual-cycle-insulin-sensitivity/Medxy AIvi2026-09-06T09:52:06-07:00Chu kỳ kinh nguyệt ảnh hưởng thế nào đến độ nhạy insulin ở đái tháo đường týp 1? Góc nhìn từ người dùng hệ thống truyền insulin tự động https://news.medxy.ai/menstrual-cycle-influence-on-insulin-sensitivity-in-type-1-diabetes-insights-from-automated-insulin-delivery-users/Medxy AIen2026-09-06T09:51:39-07:00Menstrual Cycle Influence on Insulin Sensitivity in Type 1 Diabetes: Insights from Automated Insulin Delivery Users https://news.medxy.ai/zh/obesity-driven-afib/Medxy AIzh2026-09-06T09:50:56-07:00肥胖驱动的心房颤动患者左心房重构：来自有创压力-容积分析的启示 https://news.medxy.ai/ja/71161-2/Medxy AIja2026-09-06T09:50:31-07:00心房細動における肥満に起因する左房リモデリング：侵襲的圧・容積解析による知見 https://news.medxy.ai/vi/71159-2/Medxy AIvi2026-09-06T09:50:02-07:00Tái cấu trúc tâm nhĩ trái do béo phì trong rung nhĩ: Những hiểu biết từ phân tích xâm lấn mối tương quan áp lực – thể tích https://news.medxy.ai/obesity-driven-left-atrial-remodeling-in-atrial-fibrillation-insights-from-invasive-pressure-volume-analysis/Medxy AIen2026-09-06T09:49:34-07:00Obesity-Driven Left Atrial Remodeling in Atrial Fibrillation: Insights from Invasive Pressure-Volume Analysis https://news.medxy.ai/zh/left-ventricle-right-atria-strain/Medxy AIzh2026-09-06T09:48:51-07:00左心室与右心房应变联合评估：提升肺动脉高压预后预测的新策略 https://news.medxy.ai/ja/71152-2/Medxy AIja2026-09-06T09:48:31-07:00肺動脈性肺高血圧症における予後予測精度の向上に向けた左室および右房ストレインの統合 https://news.medxy.ai/vi/left-ventricle-right-atrial-strain/Medxy AIvi2026-09-06T09:48:07-07:00Kết hợp biến dạng thất trái và nhĩ phải để nâng cao dự đoán tiên lượng trong tăng áp động mạch phổi https://news.medxy.ai/integrating-left-ventricular-and-right-atrial-strain-for-enhanced-prognostic-prediction-in-pulmonary-arterial-hypertension/Medxy AIen2026-09-06T09:47:39-07:00Integrating Left Ventricular and Right Atrial Strain for Enhanced Prognostic Prediction in Pulmonary Arterial Hypertension https://news.medxy.ai/zh/bilateral-vs-unilateral-ita/Medxy AIzh2026-09-06T09:46:58-07:00双侧与单侧胸廓内动脉移植在冠脉旁路手术中的长期结局比较 https://news.medxy.ai/ja/coronary-bypass-graft-comparison/Medxy AIja2026-09-06T09:46:34-07:00冠動脈バイパス術における両側内胸動脈グラフトと単独内胸動脈グラフトの長期成績比較 https://news.medxy.ai/vi/71139-2/Medxy AIvi2026-09-06T09:46:05-07:00So sánh kết quả dài hạn của phẫu thuật bắc cầu động mạch vành sử dụng động mạch vú trong hai bên so với một bên https://news.medxy.ai/long-term-comparative-outcomes-of-bilateral-versus-single-internal-thoracic-artery-grafts-in-coronary-bypass-surgery/Medxy AIen2026-09-06T09:45:44-07:00Long-Term Comparative Outcomes of Bilateral versus Single Internal Thoracic Artery Grafts in Coronary Bypass Surgery https://news.medxy.ai/zh/71133-2/Medxy AIzh2026-09-06T09:45:01-07:00多基因风险评分提升了对外周动脉疾病及肢体相关事件的预测能力 https://news.medxy.ai/ja/71130-2/Medxy AIja2026-09-06T09:44:39-07:00遺伝学的知見の活用：ポリジェニック・リスク・スコアが末梢動脈疾患および四肢イベントの予測能を向上させる https://news.medxy.ai/vi/71126-2/Medxy AIvi2026-09-06T09:44:15-07:00Tận dụng thông tin di truyền: Điểm nguy cơ đa gen giúp nâng cao khả năng dự báo bệnh động mạch ngoại biên và các biến cố chi https://news.medxy.ai/harnessing-genetic-insights-polygenic-risk-score-enhances-prediction-of-peripheral-artery-disease-and-limb-events/Medxy AIen2026-09-06T09:43:49-07:00Harnessing Genetic Insights: Polygenic Risk Score Enhances Prediction of Peripheral Artery Disease and Limb Events https://news.medxy.ai/zh/ryr2-cpvt-risk-model/Medxy AIzh2026-09-06T09:43:00-07:00RYR2介导CPVT在β受体阻滞剂治疗下的已验证风险分层模型 https://news.medxy.ai/ja/71118-2/Medxy AIja2026-09-06T09:42:38-07:00β遮断薬治療下におけるRYR2関連カテコラミン感受性多形性心室頻拍の検証済みリスク層別化 https://news.medxy.ai/vi/ryr2-cpvt-risk/Medxy AIvi2026-09-06T09:42:14-07:00Phân tầng nguy cơ đã được xác thực ở CPVT trung gian bởi RYR2 trong điều trị bằng thuốc chẹn beta https://news.medxy.ai/validated-risk-stratification-for-ryr2-mediated-catecholaminergic-polymorphic-ventricular-tachycardia-on-beta-blocker-therapy/Medxy AIen2026-09-06T09:41:50-07:00Validated Risk Stratification for RYR2-Mediated Catecholaminergic Polymorphic Ventricular Tachycardia on Beta-Blocker Therapy https://news.medxy.ai/zh/stent-thrombectomy-infarct-reduction/Medxy AIzh2026-09-06T09:41:09-07:00支架取栓可缩小高血栓负荷心肌梗死的梗死面积：NATURE 试验带来的新启示 https://news.medxy.ai/ja/stent-thrombectomy-effectiveness/Medxy AIja2026-09-06T09:40:46-07:00高血栓負荷心筋梗塞におけるステントリトリーバー血栓除去術の有効性：NATURE試験から見えた梗塞縮小効果 https://news.medxy.ai/vi/71106-2/Medxy AIvi2026-09-06T09:40:22-07:00Thủ thuật lấy huyết khối bằng stent retriever giúp giảm kích thước vùng nhồi máu ở bệnh nhân nhồi máu cơ tim có khối lượng huyết khối lớn: Những thông tin từ thử nghiệm NATURE https://news.medxy.ai/stent-retriever-thrombectomy-reduces-infarct-size-in-high-thrombus-myocardial-infarction-insights-from-the-nature-trial/Medxy AIen2026-09-06T09:39:58-07:00Stent Retriever Thrombectomy Reduces Infarct Size in High-Thrombus Myocardial Infarction: Insights from the NATURE Trial https://news.medxy.ai/zh/lepodisiran-lipoprotein-a-impact/Medxy AIzh2026-09-06T09:39:16-07:00Lepodisiran 对脂蛋白(a)中氧化磷脂的影响：推动心血管风险降低研究 https://news.medxy.ai/ja/71098-2/Medxy AIja2026-09-06T09:38:53-07:00リポタンパク(a)中の酸化リン脂質に対するレポディシラン（Lepodisiran）の影響：心血管リスク低減に向けた研究の進展 https://news.medxy.ai/vi/71097-2/Medxy AIvi2026-09-06T09:38:26-07:00Tác động của Lepodisiran đối với Phospholipid bị oxy hóa trong Lipoprotein(a): Thúc đẩy nghiên cứu về giảm nguy cơ tim mạch https://news.medxy.ai/lepodisirans-impact-on-oxidized-phospholipids-in-lipoproteina-advancing-cardiovascular-risk-reduction/Medxy AIen2026-09-06T09:38:00-07:00Lepodisiran’s Impact on Oxidized Phospholipids in Lipoprotein(a): Advancing Cardiovascular Risk Reduction https://news.medxy.ai/zh/familial-hypercholesterolemia-diagnosis/Medxy AIzh2026-09-06T09:37:10-07:00突破家族性高胆固醇血症诊断：经活性归一化的 prime editing 实现 LDLR 变异全面分类 https://news.medxy.ai/ja/71092-2/Medxy AIja2026-09-06T09:36:46-07:00家族性高コレステロール血症の診断の進展：LDLRバリアントの包括的分類に向けた活性正規化プライム編集 https://news.medxy.ai/vi/71090-2/Medxy AIvi2026-09-06T09:36:17-07:00Thúc đẩy chẩn đoán Tăng cholesterol máu gia đình: Kỹ thuật Prime Editing được chuẩn hóa theo hoạt tính nhằm phân loại toàn diện các biến thể gen LDLR https://news.medxy.ai/advancing-familial-hypercholesterolemia-diagnosis-activity-normalized-prime-editing-for-comprehensive-ldlr-variant-classification/Medxy AIen2026-09-06T09:35:50-07:00Advancing Familial Hypercholesterolemia Diagnosis: Activity-Normalized Prime Editing for Comprehensive LDLR Variant Classification https://news.medxy.ai/zh/cxcl9-cxcl10-cd8-tcells-axis/Medxy AIzh2026-09-06T09:35:04-07:00瞄准CXCL9/CXCL10-CXCR3+ CD8+ T细胞轴：揭示压力负荷性心力衰竭中抗PD-1抗体相关心脏毒性的机制 https://news.medxy.ai/ja/71084-2/Medxy AIja2026-09-06T09:34:41-07:00CXCL9/CXCL10-CXCR3+ CD8+ T細胞軸を標的とする：圧負荷心不全における抗PD-1抗体関連心毒性の解明 https://news.medxy.ai/vi/cxcl9-cxcr3-cd8-tcells/Medxy AIvi2026-09-06T09:34:16-07:00Nhắm trục CXCL9/CXCL10-CXCR3+ trên tế bào T CD8+: Giải mã độc tính tim liên quan đến kháng thể kháng PD-1 trong suy tim do quá tải áp lực https://news.medxy.ai/targeting-the-cxcl9-cxcl10-cxcr3-cd8-t-cell-axis-unraveling-anti-pd-1-antibody-associated-cardiotoxicity-in-pressure-overload-heart-failure/Medxy AIen2026-09-06T09:33:51-07:00Targeting the CXCL9/CXCL10-CXCR3+ CD8+ T Cell Axis: Unraveling Anti-PD-1 Antibody-Associated Cardiotoxicity in Pressure Overload Heart Failure https://news.medxy.ai/zh/cd19-cd22-car-t/Medxy AIzh2026-09-06T09:33:06-07:00双靶点 CD19/CD22 CAR T 细胞疗法：儿童复发/难治性 B 细胞急性淋巴细胞白血病的新突破 https://news.medxy.ai/ja/dual-target-car-t-therapy-2/Medxy AIja2026-09-06T09:32:43-07:00小児再発・難治性B-ALLに挑む二重標的CAR T細胞療法：CD19/CD22の新展開 https://news.medxy.ai/vi/car-t-therapy-b-all-2/Medxy AIvi2026-09-06T09:32:13-07:00Liệu pháp CAR T tế bào nhị cấu trúc CD19/CD22: Bước tiến mới cho B-ALL tái phát/kháng trị ở trẻ em https://news.medxy.ai/bicistronic-cd19-cd22-car-t-cell-therapy-a-breakthrough-for-pediatric-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia/Medxy AIen2026-09-06T09:31:45-07:00Bicistronic CD19/CD22 CAR T-Cell Therapy: A Breakthrough for Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia https://news.medxy.ai/zh/her2-positive-breast-cancer-treatment-3/Medxy AIzh2026-09-06T09:31:03-07:00ERBB2阳性乳腺癌新辅助治疗新进展：anbenitamab联合HB1801的3期随机临床试验综述 https://news.medxy.ai/ja/erbb2-breast-cancer-trial/Medxy AIja2026-09-06T09:30:41-07:00ERBB2陽性乳がんにおける術前anbenitamab＋HB1801：第3相ランダム化比較試験レビュー https://news.medxy.ai/vi/71070-2/Medxy AIvi2026-09-06T09:30:13-07:00Những tiến bộ gần đây trong liệu pháp tân bổ trợ cho ung thư vú dương tính với ERBB2: Tổng quan về thử nghiệm lâm sàng ngẫu nhiên giai đoạn 3 đánh giá Anbenitamab kết hợp với HB1801 https://news.medxy.ai/neoadjuvant-anbenitamab-and-hb1801-in-erbb2-positive-breast-cancer-a-phase-3-randomized-clinical-trial-review/Medxy AIen2026-09-06T09:29:47-07:00Neoadjuvant Anbenitamab and HB1801 in ERBB2-Positive Breast Cancer: A Phase 3 Randomized Clinical Trial Review